Levaquin, Levofloxacin Systemic (levofloxacin) dosing, indications, interactions, adverse effects, and more LEVAQUIN ® is indicated in adult patients for the treatment of complicated urinary tract infections (mild to moderate) due to Enterococcus faecalis, Enterobacter
PMCID: PMC4892626 PMID: 27257956 Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas
LEVAQUIN ® is indicated in adult patients for the treatment of complicated urinary tract infections (mild to moderate) due to Enterococcus faecalis, Enterobacter cloacae, Escherichia coli, Klebsiella
1, 9, 10 Third Uncomplicated urinary tract infections Levofloxacin and sparfloxacin exhibit inferior in below): E
fever, AMS, malaise, lethargy, flank ciprofloxacin 500 mg BID or levofloxacin 750 mg daily or TMP-SMX one DS tablet BID If fluoroquinolone Complicated Urinary Tract Infections: 10-day Treatment Regimen
This Levofloxacin is an antibiotic that may be used to treat certain bacterial infections
The usual dose of Levofloxacin Oral Solution is 250 mg, 500 mg, or 750 mg administered orally every 24 hours, as indicated by infection and described in Table 1
Ciprofloxacin and levofloxacin dosages used to determine breakpoints are shown in Table 3
Pseudomonas sp
Autosomal dominant polycystic kidney disease (ADPKD): Evaluation and management of complicated urinary tract infections Of the currently available fluoroquinolones, only ciprofloxacin, levofloxacin, norfloxacin, and ofloxacin are indicated for UTI; gemifloxacin and moxifloxacin are not
A high-dose (750 mg) short-course (5 days) of once-daily levofloxacin is approved for use in the US in the treatment of community-acquired pneumonia (CAP), acute bacterial sinusitis (ABS), complicated urinary tract infections (UTI) and acute pyelonephritis (AP)
16 Proteus vulgaris, 10 Providencia rettgeri, 22 Pseudomonas aeruginosa, 26 Enterococcus faecalis, 20 methicillin urinary tract;